Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake

Page 6 of 8 – SEC Filing

Item 1.

(a)	Name of Issuer
	Gemphire Therapeutics Inc.
(b)	Address of Issuer’s Principal Executive Offices
	43334 Seven Mile Road, Suite 1000 Northville, MI 48167

Item 2.

(a)	Name of Person Filing
	Cormorant Global Healthcare Master Fund, LP Cormorant Global Healthcare GP, LLC Cormorant Asset Management, LLC Bihua Chen
(b)	Address of Principal Business Office or, if none, Residence
	200 Clarendon Street, 52nd Floor Boston, MA 02116
(c)	Citizenship
	Cormorant Global Healthcare Master Fund, LP – Cayman Islands Cormorant Global Healthcare GP, LLC – Delaware Cormorant Asset Management, LLC – Delaware Bihua Chen – United States
(d)	Title of Class of Securities
	Common Stock
(e)	CUSIP Number 36870A108